Senseonics Holdings, Inc.
SENS US81727U1051
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 129% | 203% | 400% | 491% | 6% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Roeder Douglas A O |
0.50 USD |
25,000 Bought |
12,500 USD |
12/12/2024 | 13/12/2024 |
| Sullivan Frederick T. CFO |
0.38 USD |
124,933 Bought |
47,475 USD |
12/12/2024 | 12/12/2024 |
| Roeder Douglas A O |
0.41 USD |
300,000 Bought |
123,000 USD |
12/12/2024 | 12/12/2024 |
| Goodnow Timothy T CEO |
0.31 USD |
315,000 Bought |
97,650 USD |
10/12/2024 | 10/12/2024 |